About Srini Pharmaceuticals Private Limited
Data last updated:
Srini Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 24 February 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG1995PTC019543. Its GSTIN is 36AACCS8456P1ZK (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2.7 Cr and a paid-up capital of ₹2.36 Cr. It was formerly known as Srini Pharmaceuticals Limited and Srini Pharmaceauticals Limited. It is led by directors Chinnapa Reddy Tera (Managing Director) and Ravali Reddy Tera (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 8 – 2 – 293/82/F/10 Plot No 10 Type – C Road No 8 Film Nagar, Hyderabad, Telangana, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹165.56 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net loss of ₹47.67 Cr (net margin -28.8%) and EBITDA of -₹17.4 Cr (EBITDA margin -10.5%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 1% over five years.
The company has about 436 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Srini Pharmaceuticals. As per MCA filings, the company has open charges of ₹120.11 Cr and satisfied charges of ₹80.58 Cr on record. Court records list 20 cases involving the company, including 15 filed by the company and 2 filed against it; 2 cases are pending. The company has 2 deals on record (2 secondary share transfers); the latest was in June 2019. Its 10 peer companies in the Pharma industry (API Manufacturers, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Grownbury Pharmaceuticals Private Limited with revenue of ₹167.88 Cr. The company has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 43 overdue payments to 10 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website srinipharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address8 – 2 – 293/82/F/10 Plot No 10 Type – C Road No 8 Film Nagar, Hyderabad, Telangana, India
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Srini Pharmaceuticals Private Limited
The main business activity of Srini Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Srini Pharmaceuticals Private Limited FY 2024 filings available
Srini Pharmaceuticals Private Limited reported revenue of ₹165.56 Cr (down 18% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Srini Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 18% fall in the latest year. EBITDA fell 499% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Srini Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹17.4 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹47.67 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Srini Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -28.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Srini Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Grownbury Pharmaceuticals Private Limited | ₹167.88 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | New Delhi, Delhi, India |
| Mac-Chem Products (India) Private Limited | ₹167.51 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Mumbai, Maharashtra, India |
| Vamsi Labs Limited | ₹167.4 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | North Solapur, Maharashtra, India |
| Flawless Pharma Private Limited | ₹167.18 Cr (FY 2023) | •••• | •••• | 2563.0% | •••• | Mumbai, Maharashtra, India |
| DWD Pharmaceuticals Limited | ₹166.47 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| Srini Pharmaceuticals Private Limited this company | ₹165.56 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Hyderabad, Telangana, India |
| Chromo Laboratories India Private Limited | ₹164.91 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Patancheru, Telangana, India |
| Calyx Chemicals and Pharmaceuticals Limited | ₹163.62 Cr (FY 2024) | •••• | •••• | -21.0% | •••• | Thane, Maharashtra, India |
| S.V. Labs Private Limited | ₹162.99 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Hyderabad, Telangana, India |
| Vasista Life Sciences Private Limited | ₹162.88 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Hyderabad, Telangana, India |
| Syntho Chirals Private Limited | ₹162.38 Cr (FY 2024) | •••• | •••• | 23.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Srini Pharmaceuticals by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals Private Limited is audited by M V Narayana Reddy & Co. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M V Narayana Reddy & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chinnapa Reddy Tera | Managing Director | 06 Oct 1997 | 29 Years 0 Months | Current |
| Ravali Reddy Tera | Whole-Time Director | 26 Dec 2022 | 3 Years 9 Months | Current |
Ownership and Shareholding of Srini Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Srini Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Mar 2026 | Hdfc Bank Limited | ₹15 Cr | Open |
| 20 Mar 2025 | Hdfc Bank Limited | ₹2.09 Cr | Open |
| 14 Dec 2022 | Hdfc Bank Limited | ₹67.69 Lakh | Open |
| 27 Oct 2021 | Hdfc Bank Limited | ₹1.37 Cr | Open |
| 25 Aug 2018 | Hdfc Bank Limited | ₹94.97 Cr | Open |
Total charge records: 10 View all charges
Deals & Funding of Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals Private Limited has 2 deals on record (2 secondary share transfers); the latest was in June 2019.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Apotex Pharmaceutical Holdings Inc |
| Jun 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals Private Limited has 20 court cases on record: 15 filed by Srini Pharmaceuticals, 2 filed against it, 3 where it is another party. 2 cases are pending and 18 are disposed. Status as checked between 29 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 18 | 1 | 1 |
| Supreme Court | 1 | 0 | 0 |
| District courts | 1 | 1 | 1 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed by the company against Southern Power Distribution Company of Telangana Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed against the company by Adarsh Chemical Industries | Pending |
| High Court for State of Telangana | Writ petition | Filed by the company against Union of India and 2 others | Pending |
| High Court of Andhra Pradesh | Writ petition | Filed by the company against State of Andhra Pradesh | Disposed |
| High Court for State of Telangana | Writ petition | Filed by the company against State of Telangana | Disposed |
Full case history
All 20 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals Private Limited has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 43 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 10)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Stanpumps Engineering Industries | •••• | •••• | •••• |
| Universal Enviro Associates | •••• | •••• | •••• |
| Vasco Scientifics Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 3 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals operates one associated brand: Srini Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical APIs and intermediates with R&D and global standards. | srinipharma.com |
Employees and EPFO Compliance at Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals Private Limited has a workforce of 436 employees as of Sep 25, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Name History of Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals has undergone 2 name changes throughout its history. The company was previously known as Srini Pharmaceuticals Limited, and Srini Pharmaceauticals Limited. The current legal name is Srini Pharmaceuticals Private Limited.
| Company Name | Status |
|---|---|
| Srini Pharmaceuticals Private Limited | Current |
| Srini Pharmaceuticals Limited | Previous |
| Srini Pharmaceauticals Limited | Previous |
CIN History of Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24231TG1995PTC019543, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG1995PTC019543 | Current |
| U24231AP1995PLC019543 | Previous |
| U24231TG1995PLC019543 | Previous |
Recent Activity on Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals Private Limited has 14 board changes on record since 1997: 2 appointments and 12 cessations. The latest: Ravali Reddy Tera was appointed as Whole-Time Director on 26 Dec 2022.
23 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Srini Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Srini Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCS8456P1ZK | Telangana | Active | 01 Jul 2017 |
| 37AACCS8456P1ZI | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Srini Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srini Pharmaceuticals Private Limited
Srini Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 24 February 1995 (31+ years old) and is registered under CIN U24231TG1995PTC019543.
Srini Pharmaceuticals reported revenue of ₹165.56 Cr for FY 2024 (down 18% YoY).
Srini Pharmaceuticals has 2 current directors:
- Chinnapa Reddy Tera - Managing Director
- Ravali Reddy Tera - Whole-Time Director
Srini Pharmaceuticals reported a net loss of ₹47.67 Cr (net margin -28.8%) and EBITDA of -₹17.4 Cr (EBITDA margin -10.5%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Srini Pharmaceuticals is -10% over three years and -1% over five years. In the latest year (FY 2024) revenue fell 18%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Srini Pharmaceuticals is 36AACCS8456P1ZK, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AACCS8456P1ZI (Andhra Pradesh).
The CIN (Corporate Identification Number) of Srini Pharmaceuticals is U24231TG1995PTC019543. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Srini Pharmaceuticals has 20 court cases on record: 15 filed by the company and 2 filed against it. 2 are pending. Most are in the high courts.
Srini Pharmaceuticals was incorporated on 24 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Hyderabad.
Srini Pharmaceuticals has 2 deals on record (2 secondary share transfers); the latest was in June 2019.
The peers of Srini Pharmaceuticals by revenue are Grownbury Pharmaceuticals Private Limited, Mac-Chem Products (India) Private Limited, Vamsi Labs Limited, Flawless Pharma Private Limited, DWD Pharmaceuticals Limited and 5 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals).
Ravali Reddy Tera was appointed as Whole-Time Director on 26 Dec 2022. Veena Keshav Reddy Gunupati ceased to be Whole-Time Director on 26 Dec 2022. James Francis Berhalter ceased to be Nominee Director on 26 Jun 2019. Srini Pharmaceuticals has 14 board changes on record in total.